NEW YORK--(BUSINESS WIRE)--
Bragar Eagel & Squire, P.C. reminds investors that the firm is investigating potential claims against DENTSPLY SIRONA Inc. (NASDAQ:XRAY) (“Dentsply”). Our investigation concerns whether Dentsply has violated the federal securities laws and/or engaged in other unlawful business practices.
On August 9, 2017, Dentsply announced earnings that fell below expectations, and also disclosed that the SEC’s Division of Enforcement asked the Company to provide documents and information concerning the Company’s accounting and disclosures, including its accounting and disclosures relating to transactions with a significant distributor of the Company. On October 2, 2017, Dentsply announced that Jeffrey T. Slovin, the Chief Executive Officer, Bret W. Wise, the Company’s Executive Chairman, and Christopher T. Clark, the Company’s President and Chief Operating Officer, Technologies, had tendered their respective resignations from employment with the Company.
Following this news, shares of Dentsply fell $3.48 per share, or over 5.8%, to close at $56.33 per share on October 2, 2017.
If you purchased or otherwise acquired Dentsply securities and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at [email protected], or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Dentsply, please go to http://www.bespc.com/dentsply. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171004006410/en/
